Induction Regimens for ANCA-Associated Vasculitis [PDF]
Ulrich, Specks +2 more
openaire +4 more sources
Biosimilar Rituximab in ANCA-Associated Vasculitis Compared to the Originator: A Multicenter Cohort Study. [PDF]
Mendel A +14 more
europepmc +1 more source
Clinical scenarios of suboptimal response to rituximab in relapsing ANCA-associated vasculitis. [PDF]
Prieto-González S +6 more
europepmc +1 more source
ANCA-associated vasculitis: addressing the emerging risk of lung cancer. [PDF]
Duncan MD.
europepmc +1 more source
Pathogenesis and therapeutic interventions for ANCA-associated vasculitis
Daigo Nakazawa +3 more
semanticscholar +1 more source
Hypogammaglobulinaemia in patients with ANCA-associated vasculitis treated with rituximab. [PDF]
Rathmann J +4 more
europepmc +1 more source
Association of FHR5 With Disease Severity in ANCA-Associated Vasculitis. [PDF]
Li YJ +7 more
europepmc +1 more source
Rituximab With or Without Avacopan in ANCA-Associated Vasculitis With Severe Renal Involvement. [PDF]
Juanet C +13 more
europepmc +1 more source
Concomitant cryoglobulinaemic vasculitis alongside ANCA-associated vasculitis: concurrence or coincidental individual occurrence. [PDF]
Whang JY +6 more
europepmc +1 more source
Therapeutic plasma exchange in paediatric ANCA-associated vasculitis: a multicentre real-world experience. [PDF]
Menentoğlu B +19 more
europepmc +1 more source

